In life sciences (40% of sales), Bio-Rad sells various life sciences tools used by research labs, biopharmaceutical manufacturers, and food testers. Example products include western blot machines ...

Bio-Rad Laboratories, Inc. (NYSE:BIO) shareholders are probably feeling a little disappointed, since its shares fell 2.6% to US$236 in the week after its latest quarterly results. Overall the ...

Jonathan DiVincenzo; President, Chief Operating Officer; Bio Rad Laboratories Inc Roop Lakkaraju; Chief Financial Officer, Executive Vice President, Principal Financial officer; Bio Rad ...

Bio-Rad Laboratories (NYSE:BIO) is set to give its latest quarterly earnings report on Thursday, 2025-05-01. Here's what investors need to know before the announcement. Analysts estimate that Bio ...

HERCULES, Calif. (AP) — HERCULES, Calif. (AP) — Bio-Rad Laboratories Inc. (BIO.B) on Thursday reported first-quarter earnings of $64 million. On a per-share basis, the Hercules, California ...

Bio-Rad reported a year-on-year decline in revenue of 1.5% at constant currency, primarily due to weak equipment sales in life sciences due to low demand from the academic research market.

My name is Desyree, and I will be your conference operator today. At this time, I would like to welcome everyone to the Bio-Rad First Quarter 2025 Earnings Results Conference Call and Webcast.

HERCULES, CA – Bio-Rad Laboratories, Inc. (NYSE:BIO), a manufacturer of laboratory analytical instruments with a market capitalization of $6.8 billion, announced the results of its Annual ...